Statistics

Total Visits

Views
Subgroup analyses from an international, doubleblind, randomised, phase 3 trial evaluating the effect of denosumab on bone metastasis-free survival in men with castrate-resistant prostate cancer24

Select a period of time:

Number of views in the range

Views
Subgroup analyses from an international, doubleblind, randomised, phase 3 trial evaluating the effect of denosumab on bone metastasis-free survival in men with castrate-resistant prostate cancer17

Views

Views
October 20240
November 20240
December 20241
January 20250
February 20251
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United Kingdom1
United States1
 

Top cities views

Views